filmov
tv
Parkinson's Disease Therapeutic Pipeline - Guest Speaker - UF PD Symposium 2023
Показать описание
Dr. Tanya Simuni from Northwestern joined us to explain how the pipeline works to get new therapies to patients with Parkinson's Disease and told us about new possible therapies that are currently being researched.
The Norman Fixel Institute for Neurological Diseases at UF Health believes that the best care and treatment for neurological disorders is personalized to the needs of each patient.
When patients visit the Fixel Institute, they can have appointments to not only see their neurologist but also receive physical therapy, occupational therapy, nutritional guidance and more – all in one central location.
Bringing all these specialties together makes the Fixel Institute the best place to take your loved one for care and treatment of Parkinson’s disease, dystonia, Tourette syndrome and tic disorders, ALS, MS, traumatic brain injury, Alzheimer’s disease and more.
The Norman Fixel Institute for Neurological Diseases at UF Health believes that the best care and treatment for neurological disorders is personalized to the needs of each patient.
When patients visit the Fixel Institute, they can have appointments to not only see their neurologist but also receive physical therapy, occupational therapy, nutritional guidance and more – all in one central location.
Bringing all these specialties together makes the Fixel Institute the best place to take your loved one for care and treatment of Parkinson’s disease, dystonia, Tourette syndrome and tic disorders, ALS, MS, traumatic brain injury, Alzheimer’s disease and more.
0:31:56
Parkinson's Disease Treatment Pipeline
0:50:19
Parkinson's Disease Therapeutic Pipeline - Guest Speaker - UF PD Symposium 2023
0:28:33
The Latest and Greatest in Parkinson Research
0:20:45
Novel Parkinson’s therapies in the Oxford Discovery pipeline - Professor Richard Wade-Martins
0:01:54
Targeting α-synuclein as a therapy for Parkinson’s disease: strategies in the pipeline
0:56:50
Updates in Therapeutics for Parkinson’s Disease
0:58:43
Human iPSC-derived Midbrain Dopaminergic Neurons for Parkinson’s Disease Modeling and Cell Therapy...
0:27:27
Parkinson Disease Research Updates 2023 | EMPOWER U Program 2023
0:00:14
2025 APDA Virtual Parkinson's Conference Session Highlights 1
0:49:21
Inhibikase Therapeutics: Developing Therapies to Reverse Parkinson’s Disease
0:33:49
Stem Cells and Parkinson's Disease
0:07:58
Rebecca Gilbert, AAN 2019 – Latest developments in the management of Parkinson's disease
0:56:58
Therapies and Research for Atypical Parkinsonisms - Symposium 2018 (MSA, PSP, CBD, DLB)
0:02:12
Key clinical trials of disease modifying therapies in Parkinson's disease
0:59:57
Webinar: 'New Treatments in Testing to Slow or Stop Parkinson's' November 2019
1:08:17
Parkinson's Disease:- 'Drug research & development review' by Dr Kevin McFarthing
0:59:54
Webinar: 'Update on Stem Cell Therapies for Parkinson's Disease' August 2019
0:02:23
Key questions for cell and gene therapy trials in Parkinson’s disease
2:56:31
Parkinson’s Disease Patient and Family Symposium 2021
0:43:33
Parkinson's Disease Gene Therapy Trials: Hype and Hope
0:21:57
Genetic Mutations in Parkinson's Disease | 2019 Udall Center Research Symposium
0:05:15
Is This The Future of Parkinson’s Drugs?
0:18:05
Drug and Target Discovery in Parkinson's Disease
0:03:43
Peter LeWitt, MD: Enhancing the Understanding of Parkinson for Therapeutic Development
Комментарии